RACK1 and non-small cell lung carcinoma: For non-digestive cancers, including non-small cell lung cancer (NSCLC), breast cancer (BC), and glioma, RACK1 is a significant biomarker of poor prognosis (Cao et al., 2010; Lv et al., 2016; Qu et al., 2017).